ID

12863

Descrizione

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02424045

collegamento

https://clinicaltrials.gov/show/NCT02424045

Keywords

versioni (1)
  1. 03/01/16 03/01/16 -
Caricato su

3 gennaio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility T-cell Lymphoma NCT02424045

Inglese

Eligibility T-cell Lymphoma NCT02424045

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologically proven aggressive t-cell non-hodgkin's lymphoma (nhl)
Descrizione

t-cell non-hodgkins lymphoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079772
2. age 18 -75 years
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
3. ann arbor stage ii, iii and iv (appendix a)
Descrizione

Lymphoma stage

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1272836
4. relapsed or refractory cases to previous treatments
Descrizione

relapse

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0277556
5. performance status (ecog) ≤ 2 (appendix b)
Descrizione

ecog

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
6. at least one or more bidimensionally measurable lesion(s)
Descrizione

lesion measurable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C1513040
≥ 2 cm by conventional ct
Descrizione

conventional tomography

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2137222
≥ 1 cm by spiral ct
Descrizione

spiral ct

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0860888
skin lesion (photographs should be taken) ≥ 2 cm
Descrizione

skin lesion

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0037284
measurable lesion by physical examination ≥ 2 cm
Descrizione

lesion measurable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C1513040
7. cardiac ejection fraction ≥ 50 % as measured by muga or 2decho without clinically significant abnormalities
Descrizione

cardiac ejection fraction; muga abnormal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232174
UMLS CUI [2]
C0853480
8. adequate renal function: serum creatinine level < 2 mg/dl (177 μmol/l)
Descrizione

renal function adequate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0205411
9. adequate liver functions: transaminase (ast/alt) < 3 x upper normal value (or < 5 x uln in the presence of dlbcl involvement of the liver), bilirubin < 2 x upper normal value (or < 5 x uln in the presence of ptcl involvement of the liver)
Descrizione

liver function adequate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0205411
10. adequate bm functions: hemoglobin ≥ 9 g/dl absolute neutrophil count (anc) ≥ 1,500/μl and platelet count ≥ 75,000/μl, unless abnormalities are due to bone marrow involvement by lymphoma
Descrizione

organ function bone marrow adequate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0205411
11. a negative serum or urine pregnancy test prior to treatment must be available both for pre-menopausal women and for women who are < 1years after the onset of menopause.
Descrizione

negative pregnancy test

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0427780
12. informed consent
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. alk-positive anaplastic large cell lymphoma and sezary syndrome.
Descrizione

alk-positive anaplastic large cell lymphoma; sezary syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1332079
UMLS CUI [2]
C0036920
2. cns or testis involvement.
Descrizione

Site of involvement Central Nervous System testis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0449683
UMLS CUI [1,2]
C3714787
UMLS CUI [1,3]
C0039597
3. previously treated with the regimen containing bendamustine or platinum agents.
Descrizione

bendamustine; platinum agents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0525079
UMLS CUI [2]
C3536920
4. any other malignancies within the past 5 years except curatively treated non-melanoma skin cancer or in situ carcinoma of cervix uteri
Descrizione

Comorbidity Malignant Neoplasms

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0006826
5. pregnant or lactating women, women of childbearing potential not employing adequate contraception
Descrizione

pregnancy; lactating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
6. other serious illness or medical conditions
Descrizione

Comorbidity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
7. unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry
Descrizione

cardiac disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018799
8. history of significant neurologic or psychiatric disorders including dementia or seizures
Descrizione

Mental disorders; dementia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004936
UMLS CUI [2]
C0497327
9. active uncontrolled infection (viral, bacterial or fungal infection)
Descrizione

comorbidity infection

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C3714514
10. other serious medical illnesses
Descrizione

comorbidity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
11. known hypersensitivity to any of the study drugs or its ingredients
Descrizione

hypersensitivity Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
12. concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy.
Descrizione

concomitant medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
Ritorna all'inizio della pagina

Similar models

Eligibility T-cell Lymphoma NCT02424045

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
t-cell non-hodgkins lymphoma
Item
1. histologically proven aggressive t-cell non-hodgkin's lymphoma (nhl)
boolean
C0079772 (UMLS CUI [1])
age
Item
2. age 18 -75 years
boolean
C0001779 (UMLS CUI [1])
Lymphoma stage
Item
3. ann arbor stage ii, iii and iv (appendix a)
boolean
C1272836 (UMLS CUI [1])
relapse
Item
4. relapsed or refractory cases to previous treatments
boolean
C0277556 (UMLS CUI [1])
ecog
Item
5. performance status (ecog) ≤ 2 (appendix b)
boolean
C1520224 (UMLS CUI [1])
lesion measurable
Item
6. at least one or more bidimensionally measurable lesion(s)
boolean
C0221198 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
conventional tomography
Item
≥ 2 cm by conventional ct
boolean
C2137222 (UMLS CUI [1])
spiral ct
Item
≥ 1 cm by spiral ct
boolean
C0860888 (UMLS CUI [1])
skin lesion
Item
skin lesion (photographs should be taken) ≥ 2 cm
boolean
C0037284 (UMLS CUI [1])
lesion measurable
Item
measurable lesion by physical examination ≥ 2 cm
boolean
C0221198 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
cardiac ejection fraction; muga abnormal
Item
7. cardiac ejection fraction ≥ 50 % as measured by muga or 2decho without clinically significant abnormalities
boolean
C0232174 (UMLS CUI [1])
C0853480 (UMLS CUI [2])
renal function adequate
Item
8. adequate renal function: serum creatinine level < 2 mg/dl (177 μmol/l)
boolean
C0232804 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
liver function adequate
Item
9. adequate liver functions: transaminase (ast/alt) < 3 x upper normal value (or < 5 x uln in the presence of dlbcl involvement of the liver), bilirubin < 2 x upper normal value (or < 5 x uln in the presence of ptcl involvement of the liver)
boolean
C0232741 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
organ function bone marrow adequate
Item
10. adequate bm functions: hemoglobin ≥ 9 g/dl absolute neutrophil count (anc) ≥ 1,500/μl and platelet count ≥ 75,000/μl, unless abnormalities are due to bone marrow involvement by lymphoma
boolean
C0678852 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
negative pregnancy test
Item
11. a negative serum or urine pregnancy test prior to treatment must be available both for pre-menopausal women and for women who are < 1years after the onset of menopause.
boolean
C0427780 (UMLS CUI [1])
informed consent
Item
12. informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
alk-positive anaplastic large cell lymphoma; sezary syndrome
Item
1. alk-positive anaplastic large cell lymphoma and sezary syndrome.
boolean
C1332079 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
Site of involvement Central Nervous System testis
Item
2. cns or testis involvement.
boolean
C0449683 (UMLS CUI [1,1])
C3714787 (UMLS CUI [1,2])
C0039597 (UMLS CUI [1,3])
bendamustine; platinum agents
Item
3. previously treated with the regimen containing bendamustine or platinum agents.
boolean
C0525079 (UMLS CUI [1])
C3536920 (UMLS CUI [2])
Comorbidity Malignant Neoplasms
Item
4. any other malignancies within the past 5 years except curatively treated non-melanoma skin cancer or in situ carcinoma of cervix uteri
boolean
C0009488 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
pregnancy; lactating
Item
5. pregnant or lactating women, women of childbearing potential not employing adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity
Item
6. other serious illness or medical conditions
boolean
C0009488 (UMLS CUI [1])
cardiac disease
Item
7. unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry
boolean
C0018799 (UMLS CUI [1])
Mental disorders; dementia
Item
8. history of significant neurologic or psychiatric disorders including dementia or seizures
boolean
C0004936 (UMLS CUI [1])
C0497327 (UMLS CUI [2])
comorbidity infection
Item
9. active uncontrolled infection (viral, bacterial or fungal infection)
boolean
C0009488 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
comorbidity
Item
10. other serious medical illnesses
boolean
C0009488 (UMLS CUI [1])
hypersensitivity Investigational New Drugs
Item
11. known hypersensitivity to any of the study drugs or its ingredients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
concomitant medication
Item
12. concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy.
boolean
C2347852 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial